As of Jul 31
| -1.09 / -1.92%|
The 16 analysts offering 12-month price forecasts for Metlife have a median target of 60.50, with a high estimate of 68.00 and a low estimate of 55.00. The median estimate represents a +8.54% increase from the last price of 55.74.
The current consensus among 21 polled investment analysts is to Buy stock in Metlife. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.